BSE See NSE See 40,544.37
112.77 (0.28%)

Suven Life Sciences secures product patents in Norway, S Korea and Singapore

Nidhi Jani
/ Categories: Markets, DSIJ Mindshare
Rate this article:

Suven Life Sciences secured product patents from Norway, South Korea and Singapore regulators corresponding to the New Chemical Entities (NCEs) for the treatment of disorders allied with Neurodegenerative diseases.

The approval of these grants is for the pipeline of molecules in CNS (Central nervous system) arena that are being developed for cognitive disorders with high unmet medical need with huge market potential globally.

Suven Life Science is mainly engaged into discovering, developing and commercializing novel pharmaceutical products.

On Thursday, the stock opened at Rs. 170.70 per share and touched an intra-day high of Rs. 175, cheering the announcement.

Previous Article Zensar to acquire Cynosure for US$33million
Next Article Ten stocks close to their 52-week high

Please login or register to post comments.